☰

Scott E. Millman, Ph.D. - Publications

Affiliations: 
2012 Basic Medical Science New York University, New York, NY, United States 
Area:
Molecular Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Busino L, Millman SE, Pagano M. SCF-mediated degradation of p100 (NF-κB2): mechanisms and relevance in multiple myeloma. Science Signaling. 5: pt14. PMID 23211527 DOI: 10.1126/Scisignal.2003408  0.498
2012 Kim DS, Zhang W, Millman SE, Hwang BJ, Kwon SJ, Clayberger C, Pagano M, Krensky AM. Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes. Blood. 120: 1658-67. PMID 22797700 DOI: 10.1182/Blood-2012-03-415968  0.408
2012 Busino L, Millman SE, Scotto L, Kyratsous CA, Basrur V, O'Connor O, Hoffmann A, Elenitoba-Johnson KS, Pagano M. Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma. Nature Cell Biology. 14: 375-85. PMID 22388891 DOI: 10.1038/Ncb2463  0.51
2011 Millman SE, Pagano M. MCL1 meets its end during mitotic arrest Embo Reports. 12: 384-385. PMID 21475247 DOI: 10.1038/Embor.2011.62  0.4
Show low-probability matches.